A recent update introduced a new bug affecting pasting in Excel Excel 2016 just got a hotfix, but Microsoft admits issues can persist Temporary workaround is available by selecting 'Paste Special' ...

Nach dem September-Update kann das Einfügen in mehreren Excel-Versionen ohne Fehlermeldung scheitern. Microsoft untersucht den Fehler und nennt inzwischen einen offiziellen Workaround. Nach dem ...

While Windows users are disappointingly familiar with updates causing problems, the same cannot be said of people using Microsoft Office. But with the release of the KB5002914 update for Excel, ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Emerging venture managers increasingly value smaller family office commitments over large ...

Read about how mathematicians are dealing with the AI takeover of their field in our newest feature here. For the second time ever, someone has solved one of the seven Millennium Prize Problems—math’s ...

The much-anticipated Lp(a)HORIZON trial testing whether the novel drug pelacarsen can improve cardiovascular outcomes by decreasing lipoprotein(a) levels has failed to meet its primary endpoint.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Novartis’ pelacarsen failed to reduce cardiovascular events despite lowering the harmful cholesterol Lp(a). The setback raises uncertainty for rival experimental Lp(a) drugs from Amgen and Eli Lilly.

Please provide your email address to receive an email when new articles are posted on . Pelacarsen did not reduce cardiovascular events in patients with elevated lipoprotein(a) compared with placebo.

Forbes contributors publish independent expert analyses and insights. Robert Glatter is a New York-based physician covering public health. This voice experience is generated by AI. Learn more. This ...

The result calls into question other late-stage trials testing Lp(a)-lowering drugs from the likes of Amgen and Eli Lilly. (iStock / Getty Images Plus) Novartis’ Ionis-partnered drug designed to lower ...